YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Company Logo Cold plasma offers opportunities in healthcare, food safety, agriculture, water treatment and manufacturing through chemical-free sterilization, surface engineering and AI-enabled automation. Dublin, Sept. 24, 2026 (GLOBE NEWS…
Key Points Interested in Apyx Medical Corporation? Here are five stocks we like better. Revenue rose 22% to $13.9 million in the second quarter, driven by a 28% increase in surgical aesthetics sales to $12.4 million, while OEM revenue decl…
Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece for the AYON platform to key surgeons in cr…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The health care sector (XLV [https://seekingalpha.com/symbol/XLV]) had its best week against the S&P 500 (SP500 [http…
Apyx Medical Corporation (NASDAQ:APYX) is one of the high-growth micro-cap stocks to buy now. On May 21, Apyx Medical Corporation (NASDAQ:APYX) announced new clinical data in Aesthetic Surgery Journal Open Forum highlighting a promising ap…
On May 14, 2026, Archon Capital Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Babcock & Wilcox Enterprises(NYSE:BW), liquidating 1,325,045 shares for an estimated $13.93 m…
On May 14, 2026, Archon Capital Management disclosed a new position in Oceaneering International(NYSE:OII), acquiring 208,000 shares in a transaction estimated at $6.73 million based on quarterly average pricing. What happened According to…
On May 14, 2026, Archon Capital Management disclosed it sold out its entire EZCORP(NASDAQ:EZPW) stake, an estimated $8.81 million transaction based on quarterly average pricing. What happened According to its SEC filing dated May 14, 2026,…
Key Points Archon Capital Management exited a position in EZCORP last quarter, selling its 367,433 shares. As a result, the quarter-end position value decreased by $7.14 million. EZCORP previously represented 4.1% of fund AUM in the prior…
Archon Capital Management opened a new position in Satellogic(NASDAQ:SATL), acquiring 1,647,687 shares in the first quarter for an estimated $6.07 million based on quarterly average pricing, according to a May 14, 2026, SEC filing. What ha…
Key Points Archon Capital Management bought 1,647,687 shares of Satellogic in the first quarter; the estimated trade size was $6.07 million (based on quarterly average prices). Meanwhile, the quarter-end position value increased by $8.96 m…
CLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (A…
Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Charles D. Goodwin Chief Financial Officer — Matthew Hill Full Conference Call Transcript Charles Goodwin: Tha…
Apyx Medical logo Key Points Apyx reported Q1 revenue of $12.5 million (up from $9.4M), driven by the commercial ramp of the AYON body‑contouring system and a 36% increase in Surgical Aesthetics to $10.7 million, and management raised full…
Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago. These figures are adjusted for non-recurring items. This qu…
Perrigo (PRGO) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items. This q…
Tilray Brands, Inc. TLRY is expected to report third-quarter fiscal 2026 results on April 1, 2026, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $205.9 million, indicating a rise of 10.9% from the figure r…
(RTTNews) - Apyx Medical Corp. (APYX), a surgical aesthetics company specialising in electrosurgical equipment and medical devices, reported a narrower net loss in the financial results for its fourth quarter and full year ended 2025, driv…
Apyx Medical logo Key Points AYON launch drove record Q4 revenue of $19.2 million (surgical aesthetics revenue up 38% to $16.7M), with AYON demand and incoming orders exceeding internal expectations and ~80% of AYON sales coming from upgra…
[Digital Intelligence - AI Icon Illuminated Against Financial Data and Binary Streams] J Studios Wall Street research looks to be shifting from endorsing the classic AI trade to AI adopters. Instead of the chipmakers and hyperscalers in th…
CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), tod…
CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), tod…
CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), toda…
This article first appeared on GuruFocus. Exploring Ken Fisher (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Warning! GuruFocus has detected 7 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our free DCF calcula…
CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and t…
Earnings Call Insights: Apyx Medical Corporation (APYX) Q2 2025 MANAGEMENT VIEW * Charles D. Goodwin, President and CEO, announced the appointment of two senior sales leaders: "John Featherstone will head North American sales and has over…
APYX MEDICAL CORP (NASDAQ:APYX [https://www.chartmill.com/stock/quote/APYX/profile]) reported its second-quarter 2025 financial results, revealing mixed performance relative to analyst expectations. The company, known for its helium plasma…
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of comm…
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and th…
The U.S. stock market has recently seen major indices like the S&P 500 and Nasdaq Composite reach new highs, buoyed by strong corporate earnings and easing trade tensions. In this context, penny stocks continue to attract interest due to t…
CLEARWATER, Fla. - Apyx Medical Corporation (NASDAQ:APYX), a $96 million market cap medical device company whose stock has surged nearly 90% over the past year, announced Monday the launch of its Renuvion technology in China following init…
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and t…
Over the last 7 days, the market has risen 1.9%, and over the past 12 months, it is up 12%, with earnings forecast to grow by 14% annually. For investors willing to explore beyond well-known companies, penny stocks—often smaller or newer e…
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies…
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, tod…
Looking at Apyx Medical Corporation's (NASDAQ:APYX ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. Although we don't…